ClinicalTrials.gov record
A Study to Evaluate the Safety and Efficacy of Ublituximab in Combination With Umbralisib for Participants Previously Enrolled in Protocol UTX-TGR-304
ClinicalTrials.gov ID: NCT02656303
Public ClinicalTrials.gov record NCT02656303. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-Center, Open-Label, Compassionate Use Extension Study of Ublituximab (TG-1101) in Combination With Umbralisib (TGR-1202) for Patients Previously Enrolled in Protocol UTX-TGR-304
Study identification
- NCT ID
- NCT02656303
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- TG Therapeutics, Inc.
- Industry
- Enrollment
- 116 participants
Conditions and interventions
Conditions
Interventions
- Ublituximab Biological
- Umbralisib Drug
Biological · Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 6, 2016
- Primary completion
- May 25, 2022
- Completion
- Jul 10, 2022
- Last update posted
- Jun 21, 2023
2016 – 2022
United States locations
- U.S. sites
- 69
- U.S. states
- 34
- U.S. cities
- 66
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| TG Therapeutics Investigational Trial Site | Huntsville | Alabama | 35805 | — |
| TG Therapeutics Investigational Trial Site | Chandler | Arizona | 85224 | — |
| TG Therapeutics Investigational Trial Site | Fayetteville | Arkansas | 72703 | — |
| TG Therapeutics Investigational Trial Site | Duarte | California | 91010 | — |
| TG Therapeutics Investigational Trial Site | Pleasanton | California | 94588 | — |
| TG Therapeutics Investigational Trial Site | San Diego | California | 92108 | — |
| TG Therapeutics Investigational Trial Site | Whittier | California | 90603 | — |
| TG Therapeutics Investigational Trial Site | Aurora | Colorado | 80012 | — |
| TG Therapeutics Investigational Trial Site | Denver | Colorado | 80218 | — |
| TG Therapeutics Investigational Trial Site | Bridgeport | Connecticut | 06606 | — |
| TG Therapeutics Investigational Trial Site | New Haven | Connecticut | 06519 | — |
| TG Therapeutics Investigational Trial Site | Stamford | Connecticut | 06904 | — |
| TG Therapeutics Investigational Trial Site | Newark | Delaware | 19713 | — |
| TG Therapeutics Investigational Trial Site | Boca Raton | Florida | 33486 | — |
| TG Therapeutics Investigational Trial Site | Fort Myers | Florida | 33916 | — |
| TG Therapeutics Investigational Trial Site | Jacksonville | Florida | 32204 | — |
| TG Therapeutics Investigational Trial Site | Jacksonville | Florida | 32256 | — |
| TG Therapeutics Investigational Trial Site | St. Petersburg | Florida | 33705 | — |
| TG Therapeutics Investigational Trial Site | Tallahassee | Florida | 32308 | — |
| TG Therapeutics Investigational Trial Site | West Palm Beach | Florida | 33401 | — |
| TG Therapeutics Investigational Trial Site | Albany | Georgia | 31701 | — |
| TG Therapeutics Investigational Trial Site | Chicago | Illinois | 60612 | — |
| TG Therapeutics Investigational Trial Site | Peoria | Illinois | 61615 | — |
| TG Therapeutics Investigational Trial Site | Swansea | Illinois | 62526 | — |
| TG Therapeutics Investigational Trial Site | Urbana | Illinois | 61801 | — |
| TG Therapeutics Investigational Trial Site | Fort Wayne | Indiana | 46804 | — |
| TG Therapeutics Investigational Trial Site | Indianapolis | Indiana | 46237 | — |
| TG Therapeutics Investigational Trial Site | Westwood | Kansas | 66210 | — |
| TG Therapeutics Investigational Trial Site | Louisville | Kentucky | 40207 | — |
| TG Therapeutics Investigational Trial Site | Worcester | Massachusetts | 01608 | — |
| TG Therapeutics Investigational Trial Site | Ann Arbor | Michigan | 48197 | — |
| TG Therapeutics Investigational Trial Site | Detroit | Michigan | 48202 | — |
| TG Therapeutics Investigational Trial Site | Jackson | Michigan | 49201 | — |
| TG Therapeutics Investigational Trial Site | Saint Louis Park | Minnesota | 55416 | — |
| TG Therapeutics Investigational Trial Site | Kansas City | Missouri | 64132 | — |
| TG Therapeutics Investigational Trial Site | Lincoln | Nebraska | 68510 | — |
| TG Therapeutics Investigational Trial Site | Lebanon | New Hampshire | 03756 | — |
| TG Therapeutics Investigational Trial Site | Morristown | New Jersey | 07932 | — |
| TG Therapeutics Investigational Trial Site | Glens Falls | New York | 12801 | — |
| TG Therapeutics Investigational Trial Site | Syracuse | New York | 13210 | — |
| TG Therapeutics Investigational Trial Site | Charlotte | North Carolina | 28204 | — |
| TG Therapeutics Investigational Trial Site | Durham | North Carolina | 27705 | — |
| TG Therapeutics Investigational Trial Site | Durham | North Carolina | 27710 | — |
| TG Therapeutics Investigational Trial Site | Hickory | North Carolina | 28602 | — |
| TG Therapeutics Investigational Trial Site | Kinston | North Carolina | 28501 | — |
| TG Therapeutics Investigational Trial Site | Washington | North Carolina | 27889 | — |
| TG Therapeutics Investigational Trial Site | Canton | Ohio | 44718 | — |
| TG Therapeutics Investigational Trial Site | Toledo | Ohio | 43623 | — |
| TG Therapeutics Investigational Trial Site | Portland | Oregon | 97227 | — |
| TG Therapeutics Investigational Trial Site | Portland | Oregon | 98684 | — |
| TG Therapeutics Investigational Trial Site | Springfield | Oregon | 97477 | — |
| TG Therapeutics Investigational Trial Site | Camp Hill | Pennsylvania | 17011 | — |
| TG Therapeutics Investigational Trial Site | Hershey | Pennsylvania | 17033 | — |
| TG Therapeutics Investigational Trial Site | Philadelphia | Pennsylvania | 19106 | — |
| TG Therapeutics Investigational Trial Site | Pittsburgh | Pennsylvania | 15224 | — |
| TG Therapeutics Investigational Trial Site | Pawtucket | Rhode Island | 02860 | — |
| TG Therapeutics Investigational Trial Site | Greenville | South Carolina | 29605 | — |
| TG Therapeutics Investigational Trial Site | Sioux Falls | South Dakota | 57105 | — |
| TG Therapeutics Investigational Trial Site | Chattanooga | Tennessee | 37404 | — |
| TG Therapeutics Investigational Trial Site | Nashville | Tennessee | 37203 | — |
| TG Therapeutics Investigational Trial Site | Fort Worth | Texas | 76104 | — |
| TG Therapeutics Investigational Trial Site | San Antonio | Texas | 78240 | — |
| TG Therapeutics Investigational Trial Site | Ogden | Utah | 84405 | — |
| TG Therapeutics Investigational Trial Site | Blacksburg | Virginia | 24060 | — |
| TG Therapeutics Investigational Trial Site | Charlottesville | Virginia | 22908 | — |
| TG Therapeutics Investigational Trial Site | Fort Belvoir | Virginia | 22060 | — |
| TG Therapeutics Investigational Trial Site | Seattle | Washington | 98109 | — |
| TG Therapeutics Investigational Trial Site | Spokane | Washington | 99216 | — |
| TG Therapeutics Investigational Trial Site | Wauwatosa | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 18 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02656303, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 21, 2023 · Synced Jun 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02656303 live on ClinicalTrials.gov.